Revenue
2020
2021
2022
2023
2024
2025
NeuroPace Inc (NPCE)
Price$14.25Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $100.0M | $79.9M | $65.4M | $45.5M | $45.2M | $41.1M |
| Gross profit | $77.2M | $59.1M | $48.1M | $32.5M | $33.4M | $30.3M |
| Gross margin | 77.23% | 73.94% | 73.56% | 71.38% | 74.00% | 73.59% |
| Research & development | $27.9M | $23.7M | $20.8M | $21.9M | $18.2M | $15.7M |
| Operating expenses | $93.6M | $80.8M | $75.3M | $73.3M | $57.2M | $43.3M |
| Operating income | −$16.3M | −$21.7M | −$27.2M | −$40.8M | −$23.7M | −$13.1M |
| Operating margin | −16.34% | −27.12% | −41.54% | −89.62% | −52.54% | −31.72% |
| EBITDA | −$16.1M | −$21.5M | −$27.0M | −$40.5M | −$23.4M | −$12.7M |
| EBITDA margin | −16.10% | −26.86% | −41.27% | −89.03% | −51.88% | −30.97% |
| Net income | −$21.5M | −$27.1M | −$33.0M | −$47.1M | −$36.1M | −$24.3M |
| Net profit margin | −21.47% | −33.97% | −50.38% | −103.43% | −79.85% | −59.02% |
| Basic EPSper basic share | -$0.66 | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 |
| Diluted EPSper diluted share | -$0.66 | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 |
Owners
Reported shareholders
≈12.98%of listed shares
Geiger Uri4.45M shares · Jun 19, 2026
View holders
| Holder | % owned |
|---|---|
Geiger Uri | ≈12.98%4.45M shares |
Polar Capital Holdings Plc | 9.62%3.3M shares |
Soleus Capital Management, L.P. | 8.49%2.91M shares |
First Light Asset Management, LLC | 8.35%2.86M shares |
MORGAN STANLEY | 7.74%2.65M shares |
BlackRock, Inc. | 7.23%2.48M shares |
ORBIMED ADVISORS LLC | 4.39%1.51M shares |
Driehaus Capital Management LLC | 4.22%1.45M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.58%1.23M shares |
DEUTSCHE BANK AG\ | 2.74%938.92K shares |
ARMISTICE CAPITAL, LLC | 2.02%692K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.94%666.3K shares |
Fischer Frank M | ≈1.75%599.53K shares |
FMR LLC | 1.62%554.77K shares |
STATE STREET CORP | 1.60%550.13K shares |
LACOB JOSEPH | ≈1.07%366.48K shares |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.00%344.12K shares |
NORTHERN TRUST CORP | 0.76%260.03K shares |
Qube Research & Technologies Ltd | 0.65%221.24K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.64%220.37K shares |
Percentages use 34.28M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 15, 2025Form 4 | Morrell MarthaCHIEF MEDICAL OFFICER | SellCommon Stock | 25.0K | $15.97 | $399.3K | 50.0K |
| May 14, 2025Form 4 | ORBIMED ADVISORS LLC +1TenPercentOwner | SellCommon Stock · indirect | 34.0K | $15.94 | $542.0K | 3.24M |
| May 14, 2025Form 4 | ORBIMED ADVISORS LLC +1TenPercentOwner | SellCommon Stock · indirect | 134.1K | $15.83 | $2.12M | 3.27M |
| Feb 21, 2025Form 4 | Morrell MarthaCHIEF MEDICAL OFFICER | SellCommon Stock | 78.3K | $13.72 | $1.07M | 82.0K |
| Feb 20, 2025Form 4 | KCK LTD.TenPercentOwner | SellCommon Stock | 5.27M | $9.40 | $49.55M | 0 |